A day after Novo Nordisk (NVO) CEO Lars Fruergaard Jørgensen was grilled by a U.S. Senate committee, Cantor Fitzgerald ...
Hosted on MSN4mon
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D ChargesCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on the shares of Eli Lilly And Co (NYSE:LLY) and maintained a price target of $885. The company is slated to report its second ...
Louise Chen is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hookipa Pharma (HOOK – Research Report) ...
Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Pfizer (PFE – Research Report) yesterday and set a price target of $45.00. The company’s shares closed yesterday at $28.64.
Thank you for standing by. Welcome to the Merck & Co. Q3 sales and earnings conference call. (Operator Instructions) This call is being recorded. If you have any objections, you may disconnect at this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback